Levetiracetam Winthrop (Levetiracetam)

Levetiracetam exerts its antiepileptic effect by binding to the synaptic vesicle protein SV2A. This binding modulates neurotransmitter release, stabilising neuronal firing and lowering the excitability that can trigger seizure activity.

The dosage of Levetiracetam Winthrop is individualized. A qualified prescriber determines the appropriate dose based on the patient’s age, weight, renal function, seizure type and response to therapy. Patients should follow the prescribing clinician’s instructions precisely.

The safety of levetiracetam in pregnancy and lactation has not been fully established. It is classified as pregnancy category unknown. Clinicians must weigh potential benefits against possible risks and discuss options with the patient before use.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and necessary import documentation.

Levetiracetam offers a favourable safety profile and minimal drug‑enzyme interactions compared with many older antiepileptics such as carbamazepine or phenytoin. It is often chosen for patients who require a medication with fewer hepatic metabolism concerns, though individual response and tolerability vary.

Store the tablets at ambient temperature, below 25 °C, in the original packaging. Protect them from moisture, excessive heat and direct light. Do not store in the bathroom or near a kitchen sink to maintain product stability.

Levetiracetam Winthrop is taken orally. Swallow the tablet whole with a glass of water; it may be taken with or without food. Follow the prescriber’s dosing schedule to maintain consistent blood levels.

Serious adverse events include severe skin reactions such as Stevens‑Johnson syndrome or toxic epidermal necrolysis, and psychiatric effects like suicidal thoughts or severe mood changes. Patients should seek immediate medical attention if they notice rash, blistering, or new depressive or suicidal symptoms.

Patients with known hypersensitivity to levetiracetam or any of the tablet’s excipients should avoid the medication. Caution is advised in individuals with severe renal impairment, as dose adjustment may be required, and in those with uncontrolled psychiatric conditions.